Literature DB >> 15975101

Impaired vascular function during short-term poor glycaemic control in Type 1 diabetic patients.

V R Sørensen1, E R Mathiesen, P Clausen, A Flyvbjerg, B Feldt-Rasmussen.   

Abstract

AIM: To study the effects of short-term poor glycaemic control on vascular function in Type 1 diabetic patients.
METHODS: Ten Type 1 diabetic patients, with diabetes duration of less than 10 years and normal urinary albumin excretion and ophthalmoscopy, were studied. All patients were examined after 48 h of good vs. poor glycaemic control within a 3-week period. Blood glucose was measured seven times daily for 2 days before each examination. External ultrasound was used to measure the dilatory response of the brachial artery to post-ischaemic increased blood flow (endothelium-dependent dilation) and to nitroglycerin (endothelium-independent dilation). Plasma concentration of von Willebrand factor antigen, adhesion molecules, vascular endothelial growth factor, homocystein and cholesterol were also measured.
RESULTS: The median blood glucose levels in the 48 h before the examinations were [median (range), good vs. poor control]: 6.3 (5.0-7.6) vs. 15.9 (11.3-17.8) (mmol/l). The flow-associated vasodilation (% of baseline) was reduced during poor control: 102.7 (94.7-110.8) vs. 104.0 (99.6-118.5) (P < 0.05) as were the nitroglycerin-induced dilation (% of baseline): 114.5 (103.3-127.9) vs. 120.2 (106.8-148.0) (P < 0.05). P-von Willebrand factor antigen was high during poor control (kIU/l): 1.14 (0.73-1.84) vs. 0.86 (0.72-1.39) (P < 0.05) and so was P-vascular endothelial growth factor (ng/l): 288 (133-773) vs. 254 (90-383) (P < 0.05).
CONCLUSIONS: Short-term (48 h) hyperglycaemia in Type 1 diabetic patients may disturb vascular function, possibly mediated through smooth muscle cell dysfunction as well as endothelial dysfunction. We suggest that prolonged and repeated episodes of hyperglycaemia could possibly lead to permanent vascular dysfunction and thereby development and progression of vascular complications in diabetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15975101     DOI: 10.1111/j.1464-5491.2005.01543.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  9 in total

Review 1.  Endothelial dysfunction as a predictor of cardiovascular disease in type 1 diabetes.

Authors:  Marcello C Bertoluci; Gislaine V Cé; Antônio Mv da Silva; Marco V Wainstein; Winston Boff; Marcia Puñales
Journal:  World J Diabetes       Date:  2015-06-10

2.  Vascular smooth muscle responsiveness to nitric oxide is reduced in healthy adults with increased adiposity.

Authors:  Demetra D Christou; Gary L Pierce; Ashley E Walker; Moon-Hyon Hwang; Jeung-Ki Yoo; Meredith Luttrell; Thomas H Meade; Mark English; Douglas R Seals
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-07-20       Impact factor: 4.733

3.  Alterations in arterial pressure in patients with Type 1 diabetes are associated with long-term poor metabolic control and a more atherogenic lipid profile.

Authors:  F J Vílchez-López; F Carral-Sanlaureano; C Coserria-Sánchez; A Nieto; S Jiménez; M Aguilar-Diosdado
Journal:  J Endocrinol Invest       Date:  2010-08-31       Impact factor: 4.256

4.  Protein kinase C-β contributes to impaired endothelial insulin signaling in humans with diabetes mellitus.

Authors:  Corey E Tabit; Sherene M Shenouda; Monica Holbrook; Jessica L Fetterman; Soroosh Kiani; Alissa A Frame; Matthew A Kluge; Aaron Held; Mustali M Dohadwala; Noyan Gokce; Melissa G Farb; James Rosenzweig; Neil Ruderman; Joseph A Vita; Naomi M Hamburg
Journal:  Circulation       Date:  2012-11-30       Impact factor: 29.690

5.  Effect of interactions between C peptide levels and insulin treatment on clinical outcomes among patients with type 2 diabetes mellitus.

Authors:  Gary T C Ko; Wing-Yee So; Peter C Tong; Wing-Bun Chan; Xilin Yang; Ronald C Ma; Alice P Kong; Risa Ozaki; Chun-Yip Yeung; Chun-Chung Chow; Juliana C Chan
Journal:  CMAJ       Date:  2009-04-28       Impact factor: 8.262

6.  Sarpogrelate inhibits the expression of ICAM-1 and monocyte-endothelial adhesion induced by high glucose in human endothelial cells.

Authors:  Ying Su; Nan Mao; Min Li; Xia Dong; Fan-Zhen Lin; Ying Xu; Yan-Bo Li
Journal:  Mol Cell Biochem       Date:  2012-10-31       Impact factor: 3.396

7.  Impaired collateral recruitment and outward remodeling in experimental diabetes.

Authors:  Jolanda M van Golde; Matthijs S Ruiter; Nicolaas C Schaper; Stefan Vöö; Johannes Waltenberger; Walter H Backes; Mark J Post; Maya S Huijberts
Journal:  Diabetes       Date:  2008-07-15       Impact factor: 9.461

8.  Study of ambulatory blood pressure in diabetic children: prediction of early renal insult.

Authors:  Nehad Mohamed Shalaby; Naglaa M Shalaby
Journal:  Ther Clin Risk Manag       Date:  2015-10-05       Impact factor: 2.423

9.  Establishment of an Animal Model of Bisphosphonate-Related Osteonecrosis of the Jaws in Spontaneously Diabetic Torii Rats.

Authors:  Kazuki Takaoka; Michiyo Yamamura; Toshihiro Nishioka; Tetsuya Abe; Joji Tamaoka; Emi Segawa; Masami Shinohara; Haruyasu Ueda; Hiromitsu Kishimoto; Masahiro Urade
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.